IP Library Patent Application 11610372
Patent Application
App. No. 11/610,372

Method of Packaging a Lens

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/610,372
Filed
Dec 13, 2006
Art Unit
3788
USPC
206/5.1
Abstract

A contact lens package includes a sealed receptacle containing a contact lens immersed in a sterile solution. The contact lens is made of a silicone hydrogel copolymer, and the solution includes a stabilizing agent in an amount effective to inhibit changes in physical properties of the silicone hydrogel copolymer.

Claims (30)

1 . A contact lens package including a sealed receptacle containing a contact lens immersed in a sterile solution, wherein the contact lens is made of a silicone hydrogel copolymer, and the solution comprises a stabilizing agent in an amount effective to inhibit changes in physical properties of the silicone hydrogel copolymer.

2 . The package of claim 1 , wherein the silicone hydrogel copolymer is ionic.

3 . The package of claim 2 , wherein the silicone hydrogel copolymer is anionic.

4 . The package of claim 2 , wherein the silicone hydrogel copolymer is cationic.

5 . The package of claim 2 , wherein the stabilizing agent is an amine that complexes with anionic groups of the copolymer.

6 . The package of claim 5 , wherein the stabilizing agent is selected from the group consisting of: amino hydrocarbons; amino alcohols; and amino acids.

7 . The package of claim 3 , wherein the stabilizing agent is a quaternary ammonium-containing compound that forms an ionic complex with anionic groups of the copolymer.

8 . The package of claim 4 , wherein the stabilizing agent includes anionic groups that complex with the cationic groups of the copolymer.

9 . The package of claim 2 , wherein the stabilizing agent contains groups that hydrogen bond with the ionic groups of the copolymer.

10 . The package of claim 9 , wherein the stabilizing agent is selected from the group consisting of: poly(vinylpyrrolidinone)s; poly(ethylene glycol)s; poly(vinyl alcohol)s; poly(propylene glycol)s; saccharides; and polyhydric alcohols.

11 . The package of claim 1 , wherein the silicone hydrogel copolymer is the polymerization product of a monomeric mixture comprising: a silicone-containing crosslinking monomer; and a hydrophilic monomer.

12 . The package of claim 11 , wherein the silicone hydrogel copolymer is the polymerization product of a monomeric mixture comprising: the silicone-containing crosslinking monomer; the hydrophilic monomer; and a monofunctional silicone-containing monomer.

13 . The package of claim 2 , wherein the silicone hydrogel copolymer is the polymerization product of a monomeric mixture comprising: a silicone-containing monomer; a hydrophilic monomer; and an ionic monomer.

14 . The package of claim 13 , wherein the ionic monomer comprises a cationic monomer, and the stabilizing agent is selected from the group consisting of MOPS, tromethamine, diglycine, and mixtures thereof.

15 . The package of claim 1 , wherein the solution has a pH of 6 to 8.

16 . The package of claim 1 , wherein the solution lacks an antimicrobial agent.

17 . The package of claim 1 , wherein the solution comprises 0.02 to 5.0 weight percent of the stabilizing agent.

18 . The package of claim 1 , wherein lidstock is sealed over the receptacle containing the solution and the contact lens.

19 . The package of claim 18 , wherein the lidstock is sealed around a perimeter of the receptacle.

20 . The package of claim 18 , wherein the solution and the contact lens are subjected to thermal energy while sealed in the package receptacle.

21 . The package of claim 20 , wherein the solution and the contact lens are heated to a temperature of at least 100° C.

22 . The package of claim 18 , wherein the solution and the contact lens are sterilized while sealed in the package receptacle.

23 . The package of claim 1 , wherein the package containing the solution and the contact lens is autoclaved.

24 . The package of claim 1 , wherein the stabilizing agent is in an amount effective to inhibit changes in modulus of the silicone hydrogel copolymer.

25 . A method comprising:

sealing a receptacle of a contact lens package that contains a solution and a contact lens, wherein the contact lens is made of a silicone hydrogel copolymer; and

storing the contact lens in the package for an extended period of time, wherein the stabilizing agent inhibits changes in physical properties of the silicone hydrogel copolymer during storage.

26 . A method of improving the hydrolytic stability of a contact lens made of a silicone hydrogel copolymer, comprising storing the contact lens in a sealed package and immersed in a sterile solution comprising a stabilizing agent, wherein the stabilizing agent inhibits changes in physical properties of the silicone hydrogel copolymer during storage.

27 . A method of increasing the shelf life of a contact lens made of a silicone hydrogel copolymer and contained in a sealed package, comprising storing the contact lens in the sealed package and immersed in a solution comprising a stabilizing agent that inhibits changes in physical properties of the silicone hydrogel copolymer during storage.

28 . A method of providing a silicone hydrogel contact lens with a shelf life of at least 3 years, comprising storing the contact lens in the sealed package and immersed in a solution comprising a stabilizing agent that inhibits changes in physical properties of the silicone hydrogel copolymer during storage.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2007
From: AMMON, DANIEL M., JR., MR.; KUNZLER, JAY F., MR.; SALAMONE, JOSEPH C., MR.; BURKE, SUSAN E., MS.; KOCH, RONALD J., MR.; LINHARDT, JEFFREY G., MR.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 019002/0763 →